Nexturastat A
-
Nexturastat A
structure -
-
CAS No:
1403783-31-2
-
Formula:
C19 H23 N3 O3
-
Chemical Name:
Nexturastat A
-
Synonyms:
Nexturastat A;Benzamide, 4-[[butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxy-;Nexturastat A 4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE;Nexturastat ABenzamide, 4-[[butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxy-;Nexturastat A, >=98%;4-[[Butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxybenzamide
- Categories:
-
CAS No:
Description
Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM; no inhibition on other HDAC forms.IC50 value: 5 nM [1]Target: HDAC6 inhibitorNexturastat A displayed low micromolar activity compared to the low nanomolar activity against HDAC6. Moreover, it also demonstrated high levels of selective inhibition against members of the related Class 2 HDAC isozymes reaching >1000-fold selective in some cases. Compared to the pan-selective HDACI LBH589, Nexturastat A is approximatel
Characteristics
81.7
2.6
1.228±0.06 g/cm3(Predicted)
1.622
H2O: Very slightly soluble (0.13 g/L) (25 ºC)
Safety Information
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Computed Properties
Molecular Weight:341.4
XLogP3:2.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:7
Exact Mass:341.17394160
Monoisotopic Mass:341.17394160
Topological Polar Surface Area:81.7
Heavy Atom Count:25
Complexity:416
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Nexturastat A
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on Nexturastat A
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
dehydrotanshinone II A
119963-50-7
-
Megalomicin A bis(potassium dihydrogen phosphate)
23319-48-4
-
methylenecyclopropyl acetyl-coenzyme A
56898-43-2
-
2-Propenenitrile, polymer with 1,3-butadiene, carboxy-terminated, polymer with bisphenol A diglycidyl ether Formula
68648-83-9
-
A 802715 Formula
107767-58-8
-
9a-aza-9a-homo Erythromycin A Formula
76820-32-1
-
gymnochrome A Structure
137363-67-8
-
Purpurea glycoside A Structure
19855-40-4
-
What is Petuniasterone A
114175-99-4
-
What is A 71623
130408-77-4